• In April 2026, Genpact’s board declared a past second-quarter cash dividend of US$0.1875 per common share, payable on June 25, 2026 to shareholders of record on June 10, 2026, while emphasizing that any future dividends remain at the board’s discretion.
• Genpact also released joint research with HFS Research showing that 92% of senior executives expect agentic AI to fundamentally change operations, yet many organizations remain constrained by process redesign, accountability gaps, and regulatory and reputational risks.
• We’ll now examine how Genpact’s leadership in agentic AI research could influence its investment narrative built around AI-driven service expansion.

Invest in the nuclear renaissance through our list of 91 elite nuclear energy infrastructure plays powering the global AI revolution.

Genpact Investment Narrative Recap

To own Genpact, you need to believe in its shift from legacy BPO to higher value, AI-enabled services, while accepting execution and competitive risks in a still-muted demand backdrop. The latest dividend declaration reinforces the existing capital return pattern but does not materially change the near term catalyst, which is whether Genpact can turn its AI and data capabilities into faster growing, higher margin Advanced Technology Solutions. The biggest risk remains that this transition does not fully offset slower core services.

The joint Genpact and HFS Research report on agentic AI is particularly relevant here, because it highlights both the opportunity in AI-driven operations and the execution hurdles around process redesign, accountability, and regulation. For investors focused on AI as a growth driver, this research underlines how much depends on Genpact’s ability to translate its thought leadership into scalable, annuity-like solutions that can support earnings growth and justify ongoing reinvestment in AI talent and platforms.

Yet behind the appeal of AI-led expansion, investors should also be aware of the risk that...

Genpact's narrative projects $6.3 billion revenue and $730.9 million earnings by 2029. This requires 7.6% yearly revenue growth and about a $178 million earnings increase from $552.5 million today.

Uncover how Genpact's forecasts yield a $48.18 fair value, a 40% upside to its current price.

Exploring Other Perspectives

Four fair value estimates from the Simply Wall St Community span roughly US$35 to just over US$109 per share, underscoring how far apart individual views can be. When you weigh these against the core risk that Advanced Technology Solutions may not fully offset slowing legacy BPO, it becomes even more important to compare several independent viewpoints before deciding how Genpact fits into your portfolio.

Explore 4 other fair value estimates on Genpact - why the stock might be worth over 3x more than the current price!

Reach Your Own Conclusion

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Genpact research is our analysis highlighting 5 key rewards that could impact your investment decision.
• Our free Genpact research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Genpact's overall financial health at a glance.

Ready For A Different Approach?

Our top stock finds are flying under the radar-for now. Get in early:

• Find 51 companies with promising cash flow potential yet trading below their fair value.
• Outshine the giants: these 18 early-stage AI stocks could fund your retirement.
• Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 31 best rare earth metal stocks of the very few that mine this essential strategic resource.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.